Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Pharma Capital, Ltd. is a private equity firm focused on the life sciences sector, founded by experienced industry executives. The firm has offices in London and New York and specializes in investment management, drug development, and strategic marketing. While specific fund size and AUM details are not disclosed, Pharma Capital operates globally, targeting preclinical and early clinical-stage therapeutics.
Pharma Capital invests directly in drug assets, particularly in preclinical and early clinical stages. The firm employs unique de-risking strategies to optimize investments and mitigate development risks, aiming to avoid costly late-stage failures while addressing high unmet medical needs in biotech and healthcare.
Email Corporate@pharmacapital.co.uk with your deck to pitch Pharma Capital.
Pharma Capital typically leads investment rounds in preclinical and early clinical-stage therapeutics, providing both capital and strategic guidance.
The firm is open to follow-on investments, particularly for companies that demonstrate significant progress in their development stages.
Specific details regarding the size of Pharma Capital's current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.